Business
Senior appointment&conversion of preference shares
Senior appointment&conversion of preference shares.
About this update from Ilika Plc
[{"type":"text","content":"\n\n \nIlika plc\n(\"Ilika\" or the \"Company\")\n \nAppointment of Vice President Product Development\n Conversion of preference shares, total voting rights and award of share options update\n \nIlika (AIM: IKA), a pioneer in solid-state battery technology, today provides an update on senior appointments, a notice of conversion of preference shares, total voting rights, and an update to staff share option awards.\n \nVP Product Development\nWith effect from 1 September 2023, Ilika has appointed Dr. Louise Turner to the role of VP Product Development. Promoted from her current position as Technical Director, Louise has demonstrated her skills in overseeing both the scientific development and scale-up activities of the Stereax® product and can draw on both her Doctorate in Chemistry and MBA in Business & Technology to further the Ilika story.\n \nLouise will take over line management responsibility for Ilika's Stereax and Goliath product development programmes from Robin Bell. Robin will continue to work with and support the Company in an advisory capacity as New Product Introduction Director where he will continue supporting each product in its journey to market.\n \nIlika's CEO Graeme Purdy, stated: \"We are delighted to have the opportunity to promote such a capable leader and scientist as Louise to the senior management team. Louise will build on the product development and commercialisation work that she has delivered with the Stereax team to the wider business helping to enact the same scale up and delivery in the Goliath product roadmaps. We look forward to continuing our relationship with Robin in his new technical consulting role.\"\n \nConversion of preference shares\nIlika announces that following receipt of conversion notices in relation to 426,300 convertible preferred Ordinary Shares of one penny each, it has today issued 426,300 Ordinary Shares. Accordingly, the Company has applied to the London Stock Exchange for 426,300 Ordinary Shares to be admitted to trading on AIM (\"Admission\"). It is expected that Admission will occur at 8:00 a.m. on 19 June 2023.\n \nTotal Voting Rights\nFollowing Admission, the Company's issued share capital will comprise 158,900,667 Ordinary Shares and that number may be used by shareholders in the Company as the denominator for...